A One Stop Shop for Everything Futures Trading

From RJO Futures | Ad

Whether you're looking to learn the basics of futures or are a seasoned vet looking to hone your trading skills, our Technical Analysis Guide has everything you need to succeed in today's futures markets!

Download your FREE Technical Analysis Trading Guide Today.

VTGN Insider Trading (VistaGen Therapeutics)

Insider Trading Chart
Insider Trading History
Frequently Asked Questions
About

Insider Ownership Percentage: 3.67%

Insider Buying (Last 12 Months): $10,237.50

Insider Selling (Last 12 Months): $147,000.00

VistaGen Therapeutics Insider Trading History Chart

VistaGen Therapeutics Share Price & Price History

^$0.17

▲ +0.0131 (8.30%)

As of 08/10/2022 06:23 PM ET

Days: 30 | 90 | 365

The Safest Option in Trades!

From Tradewins | Ad

If you’re new to trading, then you’ve probably heard the wrong thing about options—that they’re risky, unpredictable, or difficult.

And it couldn’t be more wrong! With the Hughes Optioneering Strategy, you’ll soon learn that the safest option for new accounts is options themselves!

Click here now!

VistaGen Therapeutics Insider Trading History

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
7/12/2022	Venrock Healthcare Capital Par	Major Shareholder	Sell	60,000	$0.89	$53,400.00	20,637,286
9/7/2021	Jerrold Duane Dotson	CFO	Sell	30,000	$3.12	$93,600.00	72,786
8/17/2021	H. Ralph Snodgrass	Insider	Buy	3,750	$2.73	$10,237.50
11/20/2019	H. Ralph Snodgrass	Insider	Buy	15,000	$0.34	$5,100.00	62,724

Tailor an Options Trading Strategy to Fit Your Needs

From RJO Futures | Ad

This guide will help you identify and execute an options trading strategy that fits your specific needs and risk profile.

Take your trading to the next level with the Options Strategy Guide.

Download your FREE Options Strategy Guide Today.

SEC Filings (Institutional Ownership Changes) for VistaGen Therapeutics (NASDAQ:VTGN)

67.75% of VistaGen Therapeutics stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

VistaGen Therapeutics Institutional Trading History

Reporting Date	Hedge Fund	Shares Held	Market Value	% of Portfolio	Quarterly Change in Shares	Ownership in Company
7/29/2022	Oak Family Advisors LLC	390,742	$0.34M	0.2%	+93.7%	0.189%
7/29/2022	SG Americas Securities LLC	29,443	$26K	0.0%	-75.3%	0.014%
7/27/2022	Assenagon Asset Management S.A.	360,475	$0.32M	0.0%	N/A	0.174%
7/20/2022	Exchange Traded Concepts LLC	29,136	$26K	0.0%	+337.9%	0.014%
7/19/2022	MAI Capital Management	2,661,398	$2.34M	0.0%	N/A	1.288%
7/7/2022	Epiq Partners LLC	1,301,350	$1.15M	0.7%	+12.1%	0.630%
6/7/2022	Bank of America Corp DE	155,077	$0.19M	0.0%	-71.0%	0.075%
5/17/2022	Mirabella Financial Services LLP	30,100	$37K	0.0%	N/A	0.015%
5/17/2022	Jane Street Group LLC	58,491	$73K	0.0%	N/A	0.028%
5/16/2022	California State Teachers Retirement System	82,887	$0.10M	0.0%	-22.2%	0.040%
5/16/2022	Goldman Sachs Group Inc.	655,782	$0.81M	0.0%	-45.0%	0.318%
5/16/2022	State Street Corp	3,609,840	$4.48M	0.0%	-58.0%	1.748%
5/16/2022	Ghost Tree Capital LLC	1,315,154	$1.63M	0.4%	-34.2%	0.637%
5/13/2022	Renaissance Technologies LLC	1,178,489	$1.46M	0.0%	N/A	0.571%
5/13/2022	Northern Trust Corp	1,635,003	$2.03M	0.0%	-16.3%	0.792%
5/13/2022	Charles Schwab Investment Management Inc.	553,201	$0.69M	0.0%	+14.0%	0.268%
5/13/2022	XTX Topco Ltd	91,566	$0.11M	0.0%	N/A	0.044%
5/12/2022	BlackRock Inc.	11,732,424	$14.55M	0.0%	-1.4%	5.681%
5/12/2022	Rhumbline Advisers	192,881	$0.24M	0.0%	+22.8%	0.093%
5/12/2022	MetLife Investment Management LLC	133,291	$0.17M	0.0%	+58.5%	0.065%
5/12/2022	HighTower Advisors LLC	162,078	$0.20M	0.0%	+19.1%	0.078%
5/11/2022	Bank of New York Mellon Corp	768,848	$0.95M	0.0%	-5.5%	0.372%
5/11/2022	Dorsey & Whitney Trust CO LLC	75,000	$93K	0.0%	+275.0%	0.036%
5/11/2022	JPMorgan Chase & Co.	91,139	$0.11M	0.0%	+21.4%	0.044%
5/11/2022	GSA Capital Partners LLP	73,969	$92K	0.0%	N/A	0.036%
5/10/2022	Nicholas Investment Partners LP	4,570,387	$5.67M	0.4%	+6.6%	2.213%
5/9/2022	Principal Financial Group Inc.	111,054	$0.14M	0.0%	-25.5%	0.054%
5/4/2022	Advisor Group Holdings Inc.	32,809	$41K	0.0%	-23.2%	0.016%
5/4/2022	ClariVest Asset Management LLC	252,700	$0.31M	0.0%	-12.3%	0.122%
5/3/2022	Oak Family Advisors LLC	201,727	$0.25M	0.1%	+9.3%	0.098%
4/29/2022	SG Americas Securities LLC	119,157	$0.15M	0.0%	+194.5%	0.058%
4/29/2022	Nisa Investment Advisors LLC	80,000	$99K	0.0%	N/A	0.039%
4/27/2022	Epiq Partners LLC	1,161,350	$1.44M	0.8%	+15.9%	0.562%
2/15/2022	Commodore Capital LP	8,464,999	$16.51M	3.8%	+65.2%	4.239%
2/14/2022	Parallax Volatility Advisers L.P.	94,941	$0.19M	0.0%	N/A	0.048%
2/11/2022	Eagle Asset Management Inc.	14,723	$30K	0.0%	N/A	0.007%
2/10/2022	Rafferty Asset Management LLC	490,295	$0.96M	0.0%	+98.8%	0.246%
2/9/2022	Principal Financial Group Inc.	149,035	$0.29M	0.0%	+299.9%	0.075%
2/8/2022	ProShare Advisors LLC	42,391	$82K	0.0%	+70.8%	0.021%
2/8/2022	Northern Trust Corp	1,954,286	$3.81M	0.0%	-2.2%	0.979%
2/7/2022	SG Americas Securities LLC	40,460	$79K	0.0%	-46.7%	0.020%
2/3/2022	Advisor Group Holdings Inc.	42,696	$83K	0.0%	+45.0%	0.021%
2/2/2022	New York State Common Retirement Fund	367,052	$0.72M	0.0%	+173.6%	0.184%
2/2/2022	Oak Family Advisors LLC	184,517	$0.36M	0.1%	+4.7%	0.092%
1/31/2022	CWM LLC	13,500	$26K	0.0%	N/A	0.007%
1/25/2022	Epiq Partners LLC	1,002,350	$1.96M	1.0%	+9.4%	0.502%
11/16/2021	Schonfeld Strategic Advisors LLC	422,500	$1.16M	0.0%	-31.1%	0.212%
11/16/2021	Two Sigma Advisers LP	1,109,500	$3.04M	0.0%	+75.8%	0.575%
11/16/2021	Two Sigma Investments LP	1,118,684	$3.07M	0.0%	-5.9%	0.580%
11/16/2021	Commodore Capital LP	5,123,509	$14.04M	3.7%	+53.8%	2.656%
11/15/2021	California State Teachers Retirement System	103,192	$0.28M	0.0%	-60.9%	0.053%
11/15/2021	Sphera Funds Management LTD.	3,824,938	$10.48M	0.9%	-6.3%	1.983%
11/15/2021	Zacks Investment Management	12,000	$33K	0.0%	N/A	0.006%
11/15/2021	HighVista Strategies LLC	438,239	$1.20M	0.8%	+42.2%	0.227%
11/15/2021	Franklin Resources Inc.	10,118,437	$27.73M	0.0%	+1.8%	5.245%
11/15/2021	GSA Capital Partners LLP	31,984	$88K	0.0%	N/A	0.017%
11/12/2021	The Manufacturers Life Insurance Company	103,727	$0.28M	0.0%	-6.1%	0.054%
11/12/2021	Geode Capital Management LLC	3,078,554	$8.44M	0.0%	+2.2%	1.596%
11/12/2021	EAM Global Investors LLC	634,743	$1.74M	0.4%	N/A	0.329%
11/12/2021	EAM Investors LLC	842,545	$2.31M	0.4%	+114.7%	0.437%
11/12/2021	E Fund Management Co. Ltd.	13,783	$38K	0.0%	N/A	0.007%
11/10/2021	Goldman Sachs Group Inc.	1,624,246	$4.45M	0.0%	+177.7%	0.842%
11/10/2021	Citigroup Inc.	175,052	$0.48M	0.0%	+1,822.4%	0.091%
11/10/2021	Rafferty Asset Management LLC	246,683	$0.68M	0.0%	N/A	0.128%
11/9/2021	Barclays PLC	79,396	$0.22M	0.0%	+228.0%	0.041%
11/9/2021	BlackRock Inc.	11,748,472	$32.19M	0.0%	+0.8%	6.090%
11/9/2021	Principal Financial Group Inc.	37,270	$0.10M	0.0%	+27.6%	0.019%
11/8/2021	Mackenzie Financial Corp	11,230	$31K	0.0%	N/A	0.006%
11/5/2021	Advisor Group Holdings Inc.	29,441	$81K	0.0%	+110.7%	0.015%
11/4/2021	Exencial Wealth Advisors LLC	98,731	$0.27M	0.0%	-22.2%	0.051%
11/4/2021	Deutsche Bank AG	118,795	$0.33M	0.0%	-36.3%	0.062%
11/4/2021	Financial Advocates Investment Management	23,097	$63K	0.0%	N/A	0.012%
11/2/2021	New York State Common Retirement Fund	134,173	$0.37M	0.0%	-18.1%	0.070%
11/2/2021	Victory Capital Management Inc.	795,720	$2.18M	0.0%	+76.9%	0.412%
11/1/2021	SG Americas Securities LLC	75,925	$0.21M	0.0%	N/A	0.039%
11/1/2021	Twin Lakes Capital Management LLC	94,500	$0.26M	0.2%	N/A	0.049%
10/19/2021	Epiq Partners LLC	916,100	$2.51M	1.2%	-1.8%	0.475%
10/14/2021	Genesee Capital Advisors LLC	19,860	$54K	0.0%	N/A	0.010%
9/3/2021	Parametric Portfolio Associates LLC	12,064	$38K	0.0%	N/A	0.006%
8/18/2021	Ikarian Capital LLC	916,552	$2.89M	0.2%	-68.2%	0.475%
8/17/2021	Samsara BioCapital LLC	732,596	$2.31M	0.3%	-60.0%	0.381%
8/17/2021	Beacon Pointe Advisors LLC	19,080	$60K	0.0%	N/A	0.010%
8/17/2021	Sphera Funds Management LTD.	4,080,673	$12.85M	0.9%	-2.3%	2.124%
8/17/2021	Metropolitan Life Insurance Co NY	64,386	$0.20M	0.0%	N/A	0.034%
8/17/2021	MetLife Investment Management LLC	84,097	$0.27M	0.0%	N/A	0.044%
8/17/2021	Price T Rowe Associates Inc. MD	56,771	$0.18M	0.0%	+43.7%	0.030%
8/17/2021	Prudential Financial Inc.	12,530	$39K	0.0%	N/A	0.007%
8/17/2021	Acuta Capital Partners LLC	11,728,033	$36.94M	14.8%	-4.6%	6.105%
8/17/2021	Boothbay Fund Management LLC	127,418	$0.40M	0.0%	-57.6%	0.066%
8/16/2021	AQR Capital Management LLC	109,703	$0.35M	0.0%	N/A	0.057%
8/16/2021	Amalgamated Bank	34,628	$0.11M	0.0%	N/A	0.018%
8/16/2021	California State Teachers Retirement System	264,181	$0.83M	0.0%	N/A	0.138%
8/16/2021	Commodore Capital LP	3,331,315	$10.49M	3.6%	-10.7%	1.734%
8/16/2021	Schonfeld Strategic Advisors LLC	613,600	$1.93M	0.0%	+127.4%	0.319%
8/16/2021	Charles Schwab Investment Management Inc.	474,361	$1.50M	0.0%	+853.0%	0.247%
8/16/2021	State Street Corp	3,059,610	$9.64M	0.0%	N/A	1.593%
8/16/2021	Nuveen Asset Management LLC	686,380	$2.16M	0.0%	N/A	0.357%
8/16/2021	Goldman Sachs Group Inc.	584,902	$1.84M	0.0%	+156.2%	0.304%
8/13/2021	Renaissance Technologies LLC	102,641	$0.32M	0.0%	N/A	0.053%
8/13/2021	VR Adviser LLC	16,047,286	$50.55M	6.1%	-1.6%	8.354%

Data available starting January 2016

VistaGen Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in developing and commercializing various medicines with the potential to care for anxiety, depression, and other disorders of the central nervous system (CNS). The company's CNS pipeline includes PH94B, a rapid-onset neuroactive nasal spray, which is in Phase III development for the acute treatment of anxiety in adults with social anxiety disorder. Its PH94B product candidature also has potential to treat a range of anxiety disorders, including adjustment disorder with anxiety, postpartum anxiety, post-traumatic stress disorder, preprocedural anxiety, and panic disorders. The company's CNS pipeline also comprises PH10, a rapid-onset neuroactive nasal spray, which is in preparation for Phase 2B clinical development as a stand-alone treatment for major depressive disorder (MDD); and AV-101, an oral N-methyl-D-aspartate receptor antagonist, which is in development in combination with oral probenecid as a potential treatment of levodopa-induced dyskinesia, MDD, neuropathic pain, and suicidal ideation. It has contract research and development agreement with Cato Research Ltd.; license agreement with Pherin Pharmaceuticals, Inc.; and license and collaboration agreement with EverInsight Therapeutics Inc. VistaGen Therapeutics, Inc. was founded in 1998 and is headquartered in South San Francisco, California.

Today's Range

Now: $0.17

$0.16

$0.17

50 Day Range

MA: $0.75

$0.14

$1.17

52 Week Range

Now: $0.17

$0.14

$3.26

Volume

14,489,528 shs

Average Volume

4,487,110 shs

Market Capitalization

$35.31 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

0.54

Who are the company insiders with the largest holdings of VistaGen Therapeutics?: VistaGen Therapeutics' top insider shareholders include:
Venrock Healthcare Capital Par (Major Shareholder)
Jerrold Duane Dotson (CFO)
H Ralph Snodgrass (Insider)
Learn More about top insider investors at VistaGen Therapeutics.
Who are the major institutional investors of VistaGen Therapeutics?: VistaGen Therapeutics' top institutional investors include:
MAI Capital Management — 1.29%
Epiq Partners LLC — 0.63%
Oak Family Advisors LLC — 0.19%
Assenagon Asset Management S.A. — 0.17%
SG Americas Securities LLC — 0.01%
Exchange Traded Concepts LLC — 0.01%
Learn More about top institutional investors of VistaGen Therapeutics stock.
Which major investors are selling VistaGen Therapeutics stock?: During the previous quarter, VTGN stock was sold by these institutional investors:
SG Americas Securities LLC
During the last year, company insiders that have sold VistaGen Therapeutics company stock include:
Venrock Healthcare Capital Par (Major Shareholder)
Jerrold Duane Dotson (CFO)
Learn More investors selling VistaGen Therapeutics stock.
Which major investors are buying VistaGen Therapeutics stock?: In the last quarter, VTGN stock was bought by institutional investors including:
MAI Capital Management
Assenagon Asset Management S.A.
Oak Family Advisors LLC
Epiq Partners LLC
Exchange Traded Concepts LLC
Belvedere Trading LLC

Is Apple Pointing to a Massive Recession in the U.S.?

From Chaikin Analytics | Ad

Apple (AAPL) is making moves behind the scenes to prepare for a downturn…Bloomberg recently reported that the tech giant plans to freeze hiring in some divisions- while remaining cautious on spending through next year. And the thing is, Apple isn’t alone…Bottom-line: Apple might be pointing to a massive recession in the U.S. If you have any serious assets in the market, there is one critical step you must take now.

Click for THE one critical step you must take now.